STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
ImmunityBio, Inc.
City of Hope Medical Center
Mayo Clinic
Incyte Corporation
Mayo Clinic
Yale University
University of Pittsburgh
M.D. Anderson Cancer Center
Oslo University Hospital
Merck Sharp & Dohme LLC
Incyte Corporation
University of California, San Diego
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Innovent Biologics (Suzhou) Co. Ltd.
ImaginAb, Inc.
Novartis
AstraZeneca
ImaginAb, Inc.
National Cancer Institute (NCI)
UNICANCER
University Hospital, Ghent
University of Florida
Hoffmann-La Roche
Incyte Corporation
Eastern Cooperative Oncology Group
Jules Bordet Institute
University College, London
Duke University
TC Biopharm
MultiVir, Inc.
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
St. Louis University
National Institutes of Health Clinical Center (CC)
Novartis
Seoul National University Hospital
National Institutes of Health Clinical Center (CC)
Hadassah Medical Organization
University of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Hoag Memorial Hospital Presbyterian
Hoag Memorial Hospital Presbyterian
Clinica Universidad de Navarra, Universidad de Navarra
Pfizer